Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Can inflammation lower serum zinc by redistributing it out of the bloodstream?

Inflammation can lower circulating zinc by shifting it into tissues, so a low serum zinc level may reflect inflammatory redistribution rather than true deficiency.

PlausibleJuly 26, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Inflammation can redistribute zinc out of the bloodstream and reduce circulating zinc availability, so low serum zinc may reflect inflammatory sequestration rather than simple deficiency.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that systemic inflammation reduces measurable serum zinc because zinc is moved out of circulation. The mechanism described involves inflammatory cytokines increasing hepatic zinc transport, which promotes sequestration in the liver and lowers blood zinc levels. In this framing, low serum zinc is treated as a negative acute-phase response rather than a direct measure of total body zinc stores.

Verified conclusion

Clinical and physiological context

Systemic inflammation actively disrupts systemic zinc homeostasis as part of the acute-phase response. Rather than reflecting a true nutritional depletion or a lack of total body stores, a low serum zinc level in the context of inflammation often represents a transient shift in compartmental distribution.

Mechanistic pathways

This redistribution is driven by a highly coordinated cytokine-driven signaling cascade:

  • Cytokine signaling: The onset of acute or systemic inflammation triggers the rapid release of pro-inflammatory cytokines, most notably interleukin-6 (IL-6) and interleukin-1 beta (IL-1β).
  • Transporter upregulation: These circulating cytokines act directly on hepatic tissue to upregulate the gene transcription and surface expression of the primary zinc importer, ZIP14 (SLC39A14), on the plasma membrane of hepatocytes.
  • Hepatic sequestration: Upregulated ZIP14 drives the rapid, active transport of zinc out of the vascular compartment and into the parenchyma of the liver. This hepatic sequestration effectively lowers the concentration of zinc remaining in circulation, manifesting clinically as inflammatory hypozincemia.

Clinical implications

Because circulating zinc is sequestered during active inflammatory states, interpreting serum or plasma zinc levels in patients with elevated inflammatory markers (such as C-reactive protein) is clinically challenging:

  • A depressed serum zinc value during an inflammatory flare does not reliably indicate a dietary zinc deficiency.
  • Attempting to correct this "deficiency" with high-dose nutritional supplementation may be unnecessary or ineffective, as the primary driver is the systemic redistribution of the mineral rather than an absolute depletion of body stores.

Bottom line

Serum zinc is a negative acute-phase reactant. During inflammation, cytokines upregulate hepatic ZIP14 transporters to actively sequester zinc in the liver, meaning a low serum zinc measurement often reflects inflammatory redistribution rather than a true nutritional deficiency.

References

  1. Interleukin-6 regulates the zinc transporter Zip14 in liver and ... — pubmed.ncbi.nlm.nih.gov ↗
  2. Zinc Transporter ZIP14 Functions in Hepatic Zinc, Iron and ... — journals.plos.org ↗
  3. The Multiple Faces of the Metal Transporter ZIP14 (SLC39A14) - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. Zinc Transporter ZIP14 Functions in Hepatic Zinc, Iron and ... — pmc.ncbi.nlm.nih.gov ↗
  5. Zinc and Regulation of Inflammatory Cytokines - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling — link.springer.com ↗
  7. Zinc — testguide.adhb.govt.nz ↗
  8. Zinc in Infection and Inflammation - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes. — pmc.ncbi.nlm.nih.gov ↗
  10. Bibgraph(ビブグラフ)| PubMedを日本語で論文検索 — bibgraph.hpcr.jp ↗
  11. Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation. — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→